Essential tremor (ET) is a common movement disorder. Animal studies show that histaminergic modulation may affect the pathological processes involved in the generation of ET. Histamine-3 receptor inverse agonists (H3RIA) have demonstrated attenuating effects on ET in the harmaline rat model. In this double-blind, three-way cross-over, single-dose, double-dummy study the effects of 25 mg of a novel H3RIA (MK-0249) and a stable alcohol level (0.6 g L−1) were compared with placebo, in 18 patients with ET. Tremor was evaluated using laboratory tremorography, portable tremorography and a clinical rating scale. The Leeds Sleep Evaluation Questionnaire (LSEQ) and a choice reaction time (CRT) test were performed to evaluate potential effects on sleep and attention, respectively. A steady state of alcohol significantly diminished tremor as assessed by laboratory tremorography, portable tremorography and clinical ratings compared with placebo. A high single MK-0249 dose was not effective in reducing tremor, but caused significant effects on the LSEQ and the CRT test. These results suggest that treatment with a single dose of MK-0249 does not improve tremor in alcohol-responsive patients with ET, whereas stable levels of alcohol as a positive control reproduced the commonly reported tremor-diminishing effects of alcohol.
BrennanKCJurewiczECFordBPullmanSLLouisED (2002) Is essential tremor predominantly a kinetic or a postural tremor? A clinical and electrophysiological study. Mov Disord17: 313–316.
4.
ChenJJSwopeDM (2003) Essential tremor: diagnosis and treatment. Pharmacotherapy23: 1105–1122.
5.
DeuschlGElbleRJ (2000) The pathophysiology of essential tremor. Neurology54: S14–S20.
6.
DeuschlGBainPBrinM (1998) Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord13(Suppl 3): 2–23.
7.
DeuschlGZimmermanRGengerHLuckingCH (1995) Physiologic classification of essential tremor. In: Handbook of tremor disorders. New York: Marcel Dekker, 195–208.
8.
ElbleRJ (2000) Essential tremor frequency decreases with time. Neurology55: 1547–1551.
9.
Ercan-SencicekAGStillmanAAGhoshAKBilguvarKO’RoakBJMasonCE (2010) L-histidine decarboxylase and Tourette’s syndrome. N Engl J Med362: 1901–1908.
10.
GironellAKulisevskyJBarbanojMLopez-VillegasDHernandezGPascual-SedanoB (1999) A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol56: 475–480.
GrowdonJHShahaniBTYoungRR (1975) The effect of alcohol on essential tremor. Neurology25: 259–262.
13.
HiltunenAJSaxonLSkagerbergSBorgS (2000) Acute tolerance during intravenous infusion of alcohol: Comparison of performance during ascending and steady-state concentrations – a pilot study. Alcohol22: 69–74.
14.
HindmarchIRigneyUStanleyNQuinlanPRycroftJLaneJ (2000) A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacology149: 203–216.
15.
IannoneRPalczaJRengerJJCalderNCerchioKGottesdienerK (2010) Acute alerting effects of a novel histamine subtype-3 receptor inverse agonist in healthy sleep-deprived male volunteers. Clin Pharmacol Therapeut88: 831–839.
16.
KollerWC (1991) A new drug for treatment of essential tremor? Time will tell. Mayo Clin Proc66: 1085–1087.
17.
KollerWCBiaryN (1984) Effect of alcohol on tremors: comparison with propranolol. Neurology34: 221–222.
18.
KollerWCBusenbarkKMinerK (1994) The relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study Group. Ann Neurol35: 717–723.
LouisEDBarnesLFWendtKJAlbertSMPullmanSLYuQ (2000) Validity and test-retest reliability of a disability questionnaire for essential tremor. Mov Disord15: 516–523.
25.
LouisEDOttmanRHauserWA (1998) How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world. Mov Disord13: 5–10.
26.
LouisEDWendtKJAlbertSMPullmanSLYuQAndrewsH (1999) Validity of a performance-based test of function in essential tremor. Arch Neurol56: 841–846.
27.
MartinCSMossHB (1993) Measurement of acute tolerance to alcohol in human subjects. Alcohol Clin Exp Res17: 211–216.
28.
MartinFCLeATHandforthA (2005) Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications. Mov Disord20: 298–305.
29.
NagaseTMizutaniTIshikawaSSekinoESasakiTFujimuraT (2008) Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H-3 receptor inverse agonists. J Med Chem51: 4780–4789.
30.
O’ConnorSMorzoratiSChristianJLiTK (1998) Clamping breath alcohol concentration reduces experimental variance: Application to the study of acute tolerance to alcohol and alcohol elimination rate. Alcoh Clin Exp Res22: 202–210.
31.
PahwaRLyonsKE (2003) Essential tremor: differential diagnosis and current therapy. Am J Med115: 134–142.
32.
ParrottACHindmarchI (1980) The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations – A review. Psychopharmacology71: 173–179.
33.
RajputAHJamiesonHHirshSQuraishiA (1975) Relative efficacy of alcohol and propranolol in action tremor. Can J Neurol Sci2: 31–35.
34.
SchuurmanPRBoschDABossuytPMMBonselGJvan SomerenEJWDe BieRMA (2000) A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med342: 461–468.
35.
Van HiltenJJvan DijkJGDunnewoldRJvan der VeldeEAKempBvan BrummelenP (1991) Diurnal variation of essential and physiological tremor. J Neurol Neurosurg Psychiatry54: 516–519.
YanaiKTashiroM (2007) The physiological and pathophysiological roles of neuronal histamine: An insight from human positron emission tomography studies. Pharmacol Ther113: 1–15.
38.
ZeunerKEMolloyFMShogeROGoldsteinSRWesleyRHallettM (2003) Effect of ethanol on the central oscillator in essential tremor. Mov Disord18: 1280–1285.
39.
ZoethoutRWSchoemakerRCZuurmanLvan PeltHDahanACohenAF (2009) Central nervous system effects of alcohol at a pseudo-steady-state concentration using alcohol clamping in healthy volunteers. Br J Clin Pharmacol68: 524–534.
40.
ZoethoutRWvan GervenJMDumontGJPaltansingSVan BurgelNDVan der LindenM (2008) A comparative study of two methods for attaining constant alcohol levels. Br J Clin Pharmacol66: 674–681.
